Mednet Logo
CommunityNephrology

Do you have a preference between an ACEI and ARB when initiating therapy for a patient with diabetic kidney disease, albuminuria, and hypertension?

Community PollStarted

Do you have a preference between an ACEi and ARB when initiating therapy for a patient with diabetic kidney disease, albuminuria, and hypertension?

110 physicians have voted

Join Mednetto vote and see how they answered.

7 Answers
Mednet Member
Mednet MemberInvited Expert
Nephrology · Rush Medical College
Answered on

Why would you use an ACEi over an ARB these days? Cough is a LOT more common than stated. I see patients all the time who have a ticket, an annoyance that goes away on an ARB. Also, I don't see a $ argument, nor am I aware that ACEi have even been shown to be superior to ARB for reno protection.

Als...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Nephrology · University of Mississippi Medical Center
Answered on

Assuming we are talking about type 2 diabetic patients, I prefer ARBs, as they generally have a safer side effect profile. They are also more potent as anti-hypertensive agents.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Nephrology · UAB Medicine
Answered on · Updated on

In short, no. There are outcome data supporting both ACE inhibitors and ARBs (though not together) in slowing the progression of CKD in DM nephropathy. I typically consider allergy profiles, comorbidities like respiratory disorders, and availability of combination therapies when choosing to start an...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Nephrology · Jerry L Pettis VA Medical Center
Answered on

If you are going to use losartan as a hypertensive, it needs to be given twice a day as the duration of action is 12 hours.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Nephrology · Los Angeles Vascular Access Center
Answered on

I would also use an ARB first. ACEI can cause a slightly higher incidence of hyperkalemia due to their allowing the accumulation of bradykinin, which suppresses aldosterone secretion more than ARBs.

ARB only blocks the AT1 receptor site, while ACEI prevents angiotensin II formation by all pathways....

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Nephrology · Columbus Nephrology Inc
Answered on · Updated on

I agree that ACE inhibitors are associated with more side effects compared to ARBs; however, Cheng et al., PMID 24687000 demonstrated superior cardiovascular benefits and reduced all-cause mortality in diabetic patients treated with ACE inhibitors (not a head-to-head trial; this is just a meta-analy...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Nephrology · Saint Lukes Nephrology Associates Of Carbon County
Answered on

ACEIs are more titratable in dosing but can switch to ARB if side effects are noted.

Join for free or sign in to see the full answer